NAD+ vs Sermorelin: Which Is Right for You?

NAD+ and sermorelin are both administered through Tactus Health as wellness and longevity interventions. Both are injection-based. Both target energy, cellular function, and aging-related decline. The two get grouped together in marketing because they share the longevity-supplement category, but they work through completely different mechanisms and are appropriate for different goals. Understanding the distinction will help you have a more focused conversation with our medical team about which (or whether both) makes sense for your situation.

What NAD+ Does

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell in the body, essential for cellular energy production through ATP generation, DNA repair mechanisms, and activation of sirtuins (a family of proteins associated with longevity and metabolic regulation). NAD+ is involved in hundreds of enzymatic reactions and is one of the most fundamental molecules in cellular metabolism. The National Institute on Aging overview of aging biology describes NAD+ decline as one of the well-documented hallmarks of cellular aging across multiple species.

NAD+ levels decline measurably with age, with chronic alcohol use, with metabolic stress, and in patients with chronic fatigue or post-viral conditions. The decline is roughly linear and gradual rather than sudden, and the cumulative effect on cellular function is what drives many of the visible signs of aging that people associate with general decline rather than with any one organ system. Replenishment via IV or injection bypasses digestive absorption limitations and restores intracellular levels more rapidly than oral precursor supplements such as NMN or NR.

NAD+ is most clinically relevant for patients dealing with persistent fatigue not explained by other causes, cognitive fog or memory concerns disproportionate to age and lifestyle, recovery support after periods of significant metabolic stress (illness, surgery, prolonged caloric restriction), and patients with alcohol or substance recovery history where NAD+ depletion is well-documented and clinically significant. It also has a role in general cellular longevity protocols alongside other wellness interventions, though the evidence for routine longevity use in healthy adults is more theoretical than the evidence in patients with documented depletion.

What Sermorelin Does

Sermorelin is a growth-hormone-releasing-hormone (GHRH) analog. It signals the pituitary gland to produce and release more of the body’s own natural growth hormone (HGH), working through the existing physiological release pathway rather than substituting for it. Unlike direct HGH injection, which bypasses the body’s natural regulatory feedback loop and produces supraphysiologic peaks, sermorelin works through the pituitary’s normal release mechanism to produce a physiologically appropriate HGH pulse. This makes sermorelin’s safety profile substantially more favorable than exogenous HGH, with much less risk of the side effects associated with synthetic HGH supplementation.

Growth hormone declines progressively with age, falling roughly 1 to 2 percent per year after age 30. The decline contributes to the body composition changes (reduced muscle mass, increased visceral fat), recovery slowdowns, and sleep architecture shifts that many adults experience in their 40s and 50s. Sermorelin restores GH pulsatility toward more youthful patterns without overshooting, which is the cleaner pharmacological approach to age-related GH decline.

Sermorelin is most clinically relevant for patients with reduced muscle mass or difficulty building muscle despite consistent training, increased body fat (particularly abdominal fat) despite normal diet and activity, poor sleep quality (especially reduced deep sleep, which is when GH is naturally released), slow recovery from exercise or injury, and general anti-aging metabolism optimization. Patients pursuing body composition improvement alongside their training and nutrition program tend to benefit most because sermorelin amplifies the effect of the work they are already doing rather than replacing it.

NAD+ vs Sermorelin: The Key Differences

Five differences capture the meaningful distinctions between the two interventions and clarify when each makes sense.

Mechanism. NAD+ works at the cellular energy level. It is a metabolic cofactor that participates in energy production, DNA repair, and gene expression directly inside cells. Sermorelin works at the hormonal axis level through the pituitary. It does not act on cells directly; it triggers the release of growth hormone, which then produces its effects through hormone receptors on multiple tissue types. The distinction matters because NAD+ is upstream of energy and repair regardless of system, while sermorelin’s effects are mediated through the GH and IGF-1 axis specifically.

Timeline. NAD+ effects on energy and mental clarity are often noticeable within days to weeks, particularly in patients with significant baseline depletion. Sermorelin effects on body composition and sleep develop over 3 to 6 months because the body composition changes (muscle gain, fat loss) require time even at optimal hormone levels. Patients expecting immediate body composition changes from sermorelin are usually disappointed; patients giving it 6 months alongside consistent training tend to be the most satisfied.

Administration. NAD+ is typically delivered as IV infusion for the fastest and most complete restoration, or as subcutaneous injection for maintenance after the initial IV protocol. Sermorelin is a nightly subcutaneous injection. Timing matters because it mimics the natural pulsatile GH release pattern, and dosing at bedtime aligns with the deep-sleep window when natural GH is released.

Best clinical fit. NAD+ is best for patients dealing with metabolic fatigue, cognitive fog, post-illness recovery, or alcohol or substance recovery histories. Sermorelin is best for patients pursuing body composition optimization, who want to address the GH-related dimensions of aging, or who have specific sleep architecture issues that GH-axis support might address.

Side effect profile. NAD+ is generally well-tolerated, with the main observation being a “rushing” or pressure sensation during IV infusion if the rate is too fast. Sermorelin has a slightly more involved side effect profile (mild injection site reactions, occasional vivid dreams during the first few weeks, rare elevations in blood glucose) and requires periodic monitoring of IGF-1 levels to confirm appropriate response without overshoot.

Can You Do Both?

Yes, and many patients pursuing comprehensive longevity optimization do exactly this. NAD+ and sermorelin target different physiological systems and do not interact adversely with each other. The combination is appropriate for patients addressing multiple dimensions of age-related decline simultaneously, particularly adults over 40 dealing with both the metabolic-energy side of aging (fatigue, cognitive complaints, recovery slowdown at the cellular level) and the hormonal-axis side (body composition shifts, sleep architecture changes, slowed recovery at the muscle and connective tissue level).

The practical approach for combined protocols typically begins with NAD+ during the first 4 to 8 weeks because the energy and clarity effects appear faster, providing a clearer baseline of how the patient feels before adding sermorelin. Sermorelin is then added once NAD+ status is stabilized, allowing 3 to 6 months for body composition and sleep effects to develop. Combining them from day one is also reasonable; the staggered approach is just easier for the patient to interpret which intervention is producing which observed change.

Who Is Not a Candidate

Sermorelin specifically is not appropriate for patients with active cancer (because GH-axis stimulation theoretically supports cell proliferation, including malignant cell proliferation), uncontrolled diabetes (because GH counter-regulates insulin and can worsen glucose control in insulin-resistant patients), pregnancy or active fertility planning, and patients with documented pituitary tumors or significant pituitary dysfunction. NAD+ has fewer absolute contraindications but should be used with caution in patients with active cardiac arrhythmias and in patients on multiple medications that affect cellular metabolism. The screening visit before starting either intervention is what catches these issues before treatment begins.

Common Patient Questions

How quickly will I notice differences with NAD+? Most patients describe energy and clarity improvements within the first week of starting an IV NAD+ protocol. The effect compounds over the next 4 to 6 weeks of consistent treatment. Patients with severe baseline depletion may notice changes after the first infusion; patients with subtle depletion typically need several sessions before the cumulative effect becomes evident.

How quickly will I notice differences with sermorelin? Sleep quality (deeper, more restorative sleep) is often the first noticeable change, sometimes within 2 to 3 weeks. Body composition changes (visible muscle definition, reduced visceral fat) develop over 3 to 6 months and are most visible in patients who are also training consistently. The slow timeline is real and is part of why the realistic expectation discussion happens at the start of treatment, not at month 4 when patients are wondering why they don’t look different yet.

Are oral NAD+ supplements (NMN, NR) a substitute for IV NAD+? They are partial substitutes. Oral NAD+ precursors raise NAD+ levels gradually and modestly. IV NAD+ produces faster and more complete restoration, particularly in patients with significant depletion. For maintenance once IV-restored levels are achieved, oral precursors are reasonable. For initial restoration in symptomatic patients, IV is meaningfully more effective.

Do I need both, or should I pick one? The picture matters more than the principle. Patients with primarily metabolic-energy complaints (fatigue, cognitive fog, post-illness recovery) get more value from NAD+. Patients with primarily body-composition-and-aging complaints (muscle loss, increased visceral fat, sleep architecture issues) get more value from sermorelin. Patients with both complaint patterns are reasonable candidates for combined protocols. The evaluation answers which case applies.

What does monitoring look like for sermorelin? IGF-1 levels are checked at baseline and rechecked at 3 months to confirm the dose is producing the intended effect without overshooting into supraphysiologic levels. Glucose and HbA1c are monitored because GH-axis stimulation can affect glucose regulation. Beyond that, the visit cadence is similar to other long-term wellness protocols at 3 to 6 month intervals.

The Bottom Line

NAD+ and sermorelin both belong in the longevity-medicine conversation, but they answer different clinical questions. NAD+ is the upstream cellular-energy and DNA-repair intervention, most useful when fatigue, cognitive complaints, and recovery slowdowns are the dominant pattern. Sermorelin is the pulsatile-GH intervention working through the pituitary, most useful when body composition, sleep architecture, and the hormonal side of aging are the dominant pattern. Combined protocols are reasonable when both pictures are present. The decision between them is a clinical one based on which symptom cluster is most prominent and what the patient is actually trying to address, which is exactly what the evaluation visit answers.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on wellness, hormone optimization, and medical weight loss. Sugar Hill, GA and telehealth for Georgia patients.